skip to Main Content

UCLA Researchers Identify Potential New Combination Treatment for Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Researchers from UCLA’s Jonsson Comprehensive Cancer Center have identified a possible new therapeutic strategy using two types of drug inhibitors at once to treat one of the world’s deadliest cancers. The combination approach uses one drug that inhibits the process — known as lysosome — that allows cancer cells to recycle essential nutrients to survive, and another drug that blocks the pathway used to repair DNA. Researchers found the approach to be promising after testing it on pancreatic cancer cells and mice in the laboratory.

Read more. . .

Back To Top